Thank you to @ASHE_Journal for the invite to write RE: the role of RPhs in prescribing COVID-19 antivirals.
https://t.co/Zbbv4p8Nka
A 🧵 on some key points:
Please join us for the next ID PRN Learner-Led Journal Club on Friday, September 10th at 12PM Central Time! Journal articles and other details below! Zoom passcode will be disseminated via email on the ID PRN Listserv.
Excited to see "Top Antimicrobial Stewardship Intervention Articles of 2020" (yes despite #COVID19 there were many!) published early release in @IDSAInfo jnl OFID.
Great work by network, authors & especially lead author @ViridansPharmD ! #IDTwitter
https://t.co/BnI8AIBfq0
1/ Here is a comprehensive review of the data on whether we need COVID BOOSTER SHOTS.
THE MOST IMPORTANT TAKEAWAY:
IF YOU HAVEN'T YET GOTTEN A COVID VACCINE, NOW'S THE TIME!
I'll put a Threadreader unroll at the end for those of you who find that more convenient to read/share.
@IDstewardship@bwtrautner Along the same lines of ordering cultures when indicated...I just learned that some of my nurses add water to stool samples so it will be accepted by the lab to test for C. diff 😱
@SenorCampana @jpogue1 The difference is anecdotal evidence versus controlled studies. Without a control group, you don’t really know what would have happened if they didn’t give HCQ. I discuss this paradigm in this article: https://t.co/mhgDeUKERZ
🔥🔥COVACTA study🔥🔥
Tocilizumab did NOT meet its primary endpoint of improved clinical status in hospitalised adult patients severe #COVID19 associated pneumonia. In addition, the difference in patient mortality at week four,were not MET @CarlosdelRio7
https://t.co/2W7T0e72Fq
In New prospective cohort study #CID@IDSAInfo
High incidence of invasive pulmonary aspergillosis among critically ill #COVID19 intubated patients
⛔Most patients received
corticosteroids and tocilizumab. #IDTwitter https://t.co/DK1SSOva3z
NEW🔥 @CMIJournal@BRxAD@ASP_MirandaS
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. #COVID19#IDtwitter https://t.co/bmQ6VhSn3r
"Instead of universal broad-spectrum antibiotics, the specific antibiotic regimen should be determined using a more cerebral approach." 🧠🦠💊#MedEd
https://t.co/BTbscyGLxc
June 17th, the US and #COVID19
Some people would call it a plateau.
Others will call it the 1st wave.
It is now at 80 days of >20,000 new cases/day
It is off the chart. It's a log scale.
The only country in the world
And now it's up-sloping.
@kristadgens@nbennett04@PharmerMeg We did a rough calculation of cost of drug between vanc and linezolid. But this was because we switched over to vanc premixes. With transition to auc:mic, cost of using vancomycin will be twice to three times of that to linezolid (when including lab draws and pharm time)